Browse articles from EyeWorld.org related to meibomian gland disease. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Study: low-dose pilocarpine reduces pupil diameter without significant ciliary muscle response
➤ First patient receives investigational surgical system for glaucoma
➤ Clinical program for RP gene therapy begins
➤ FDA approves IND for steroid-free, topical anti-inflammatory
➤ Compassionate use approved for investigational drug intended for neuropathic corneal pain
➤ Company news
➤ ASCRS news and events
When considering patients with dry eye, it is imperative for physicians to understand the types of dry eye disease in order to best address a patient’s issues and choose an appropriate treatment. Two specialists discussed in depth dry eye sub-types and their identification.
When treating dry eye patients, it’s possible to encounter patients who do not respond to treatment. Two experts discussed how to proceed in approaching these patients and getting them the care they need.
Meibomian gland dysfunction (MGD) is a broad term that covers various types of meibomian gland alterations. Vincent de Luise, MD, detailed the meibomian glands, how they differ in MGD, classification of MGD, and treatment options.
➤ FDA approves first standalone MIGS device
➤ Phase 3 clinical study results for inflammation, pain management nanosuspension
➤ Phase 2a clinical trial begins for investigational MGD treatment
➤ Registry created to collect data on canaloplasty
➤ ASCRS news and events
While it’s hard to determine the incidence of meibomian gland dysfunction (MGD) in children, it can be a serious issue in this population. Two ophthalmologists discussed MGD in pediatric patients and what to look for.
Rosacea can be a significant problem for many patients and may be more prevalent than physicians think. Depending on the subtype, there may be ocular involvement. Three physicians discussed treatment strategies, in addition to sharing what to look for and how to diagnose.
➤ Phase 2 results for cream to treat signs, symptoms of dry eye associated with MGD ➤ Studies support clinical value of ultra-widefield and SS-OCT imaging device ➤ New combination treatment shows promise for metastatic uveal melanoma ➤ ASCRS news and events
➤ New visual prosthesis heads to clinical trial
➤ FDA grants Fast Track designation to investigational wet AMD therapy
➤ Patient enrollment complete in Phase 3 trial for investigational, first-in-class eye drop for DED
➤ FDA agrees to pivotal trial design for investigational treatment of geographic atrophy secondary to AMD
➤ ASCRS news and events
➤ Phase 2 clinical trial of minocycline for MGD
➤ Phase 2a study of drug-eluting contact lens for glaucoma
➤ Phase 1/2 results of RNA therapy for Usher syndrome, non-syndromic retinitis pigmentosa
➤ First regulatory approval for a therapeutic contact lens that treats ocular allergies
➤ Moist heat masks effective for signs, symptoms of dry eye, study finds
➤ ASCRS Journal Club on April 8
